Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) Short Interest Down 96.3% in February

Cardiac Biotech Solutions, Inc. (OTCMKTS:CBSC) was the recipient of a large decline in short interest in the month of February. As of February 27th, there was short interest totaling 1,207 shares, a decline of 96.3% from the February 12th total of 32,799 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily trading volume, of 57,880 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 57,880 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.0% of the company’s shares are short sold.

Cardiac Biotech Solutions Price Performance

Shares of CBSC traded down $0.00 during mid-day trading on Tuesday, reaching $0.04. 100 shares of the company were exchanged, compared to its average volume of 36,596. The business has a 50 day simple moving average of $0.04 and a two-hundred day simple moving average of $0.04. Cardiac Biotech Solutions has a 52 week low of $0.02 and a 52 week high of $0.08.

Cardiac Biotech Solutions Company Profile

CB Scientific, Inc, through its US and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.